CVS Health Corporation is rated a Buy with a strong turnaround driving industry-leading results. Learn more about CVS stock ...

It’s part of a larger battle between Louisiana officials and big health care companies over prescription drug prices.

CVS Health’s stock rose more than 2% on Tuesday after the company boosted its revenue and profit guidance for the year and ...

The outlook suggests Rhode Island-based CVS expects to manage a volatile environment that has posed challenges for all three ...

The healthcare giant expects its turnaround efforts to pay off as it raised its full-year outlook and expects that momentum ...

CVS Health issued an update to its full-year guidance Tuesday ahead of its annual investor day, pointing to stronger ...

CVS Health expects 2026 profit to beat Wall Street estimates and this year's projected earnings, it said on Tuesday, ...

CVS is a strong buy now, with rising earnings, solid dividends, and steady growth prospects despite industry challenges. Read ...

CVS Health will pay $37.76 million to settle allegations it dispensed too many insulin pens to patients, and then obtained ...

Looking back at some of the themes that defined dealmaking in 2025. This special edition of the Wire highlights PE Hub’s most ...

A Florida judge on Monday declared a mistrial in a lawsuit that accused Walmart, CVS and Walgreens of flooding the state with ...

In addition to the updates for 2025, CVS offered its first look at expected earnings for 2026. The company said it ...